| Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia … L Simon, A Fitsiori, R Lemal, J Dupuis, B Carpentier, L Boudin, A Corby, ... haematologica 100 (12), 1587, 2015 | 152 | 2015 |
| Bioreactance is not reliable for estimating cardiac output and the effects of passive leg raising in critically ill patients E Kupersztych-Hagege, JL Teboul, A Artigas, A Talbot, C Sabatier, ... British journal of anaesthesia 111 (6), 961-966, 2013 | 146 | 2013 |
| High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails BR Shy, VS Vykunta, A Ha, A Talbot, TL Roth, DN Nguyen, WG Pfeifer, ... Nature biotechnology 41 (4), 521-531, 2023 | 138 | 2023 |
| The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance ID Ferguson, B Patiño-Escobar, ST Tuomivaara, YHT Lin, MA Nix, ... Nature communications 13 (1), 4121, 2022 | 69 | 2022 |
| Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation AD Petropoulou, R Porcher, RP De Latour, A Xhaard, D Weisdorf, ... Transplantation 94 (8), 879-883, 2012 | 62 | 2012 |
| Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies DB Goodman, CS Azimi, K Kearns, A Talbot, K Garakani, J Garcia, ... Science translational medicine 14 (670), eabm1463, 2022 | 56 | 2022 |
| An evolved AAV variant enables efficient genetic engineering of murine T cells WA Nyberg, J Ark, A To, S Clouden, G Reeder, JJ Muldoon, JY Chung, ... Cell 186 (2), 446-460. e19, 2023 | 51 | 2023 |
| The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling A David, S Zocchi, A Talbot, C Choisy, A Ohnona, J Lion, W Cuccuini, ... Leukemia 35 (6), 1710-1721, 2021 | 40 | 2021 |
| Plasma cell–directed therapies in monoclonal gammopathy–associated scleromyxedema T Mahévas, B Arnulf, JD Bouaziz, CB Livideanu, A Osio, A Servy, ... Blood, The Journal of the American Society of Hematology 135 (14), 1101-1110, 2020 | 37 | 2020 |
| Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia A Kreutzman, T Jaatinen, D Greco, E Vakkila, J Richter, M Ekblom, ... Experimental hematology 40 (11), 906-913. e1, 2012 | 33 | 2012 |
| Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del (1p32) remains a strong prognostic factor A Schavgoulidze, A Talbot, A Perrot, T Cazaubiel, X Leleu, S Manier, ... Blood 141 (11), 1308-1315, 2023 | 31 | 2023 |
| Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia A Talbot, RP de Latour, E Raffoux, N Buchbinder, S Vigouroux, N Milpied, ... Haematologica 99 (10), e199-e200, 2014 | 31* | 2014 |
| Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma M Fayon, C Martinez-Cingolani, A Abecassis, N Roders, E Nelson, ... Haematologica 106 (4), 1193, 2021 | 30 | 2021 |
| NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia MT Witkowski, S Lee, E Wang, AK Lee, A Talbot, C Ma, N Tsopoulidis, ... Nature immunology 23 (10), 1424-1432, 2022 | 29 | 2022 |
| Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report I Boudhabhay, C Titah, A Talbot, S Harel, J Verine, G Touchard, S Kaaki, ... Medicine 97 (52), e13638, 2018 | 23 | 2018 |
| Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series N Forgeard, D Elessa, A Carpinteiro, K Belhadj, M Minnema, M Roussel, ... Blood 143 (8), 734-737, 2024 | 19 | 2024 |
| CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment A Abecassis, N Roders, M Fayon, C Choisy, E Nelson, S Harel, B Royer, ... EJHaem 3 (3), 970-974, 2022 | 19 | 2022 |
| Peffault de Latour R, Raffoux E, et al. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia A Talbot Haematologica 99 (10), e199-e200, 2014 | 19 | 2014 |
| Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. C Boccon‐Gibod, A Talbot, F Le Bras, L Frenzel, B Royer, S Harel, ... British Journal of Haematology 189 (3), 2020 | 17 | 2020 |
| Lower respiratory tract amyloidosis: presentation, survival and prognostic factors. A multicenter consecutive case series JS Rech, B Arnulf, C de Margerie‐Mellon, A Talbot, M Malphettes, ... American Journal of Hematology 94 (11), 1214-1226, 2019 | 16 | 2019 |
Laure VINCENTMédecin hématologueBestätigte E-Mail-Adresse bei chu-montpellier.fr
